- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04805112
Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study will recruit HIV-negative adolescents girls (AG) aged 15-19 years in Siaya County, western Kenya. The study will evaluate the impact of the provision of oral HIV self-testing on uptake of testing among partners of adolescent girls. We will randomize about 300 sexually active AG to either an intervention group that receives multiple oral self-test kits that they can choose to offer to their sexual partner(s) or to a control group that will be given multiple referral coupons that their partners can use for HIV testing at pre-selected HIV testing services (HTS) sites. We will collect data on whether the kits were offered, to whom they were offered, if they were accepted, if they were used and with what results, if known, and if the partners who obtained HIV-positive results sought confirmatory testing. We will also conduct in-depth interviews with a sub-set adolescents to explore their experiences in offering HIV self-testing to their male partners.
This study has 4 specific aims: i) determine whether adolescent girls can safely offer oral HIV self-tests to their partners; ii) assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls; iii) document adverse events associated with offering oral self-testing to sexual partners of adolescent girls; and iv) qualitatively explore the experiences of adolescent girls when offering self-test kits to their partners.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Kisumu, Kenya
- Impact Research & Development Organization
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Female
- Aged 15-19 years
- HIV-negative (willing to self-test onsite in the presence of the Research Assistant who is also a trained HIV counselor)
- Has at least one current sexual partner she expects to meet at least twice in the next 3 months (not necessarily to have sex); this will provide opportunity for the participant to suggest/offer testing.
- Resides in Siaya County and does not intend to relocate within 6 months from enrollment, to allow follow up to be completed and to conduct IDI with those selected.
- Willing to be randomized into the partner self-testing or HTS referral groups.
- Reporting no incident of sexual, physical, emotional, or economic abuse in the last 12 months from the partner she intends to offer (Appendix 4) or refer for testing (Appendix 3) in the next 3 months and does not believe the partner will abuse her if she offers the self-test kits or HTS referral coupon.
- Has a male partner who has not tested for 6 months or whose HIV status is unknown to her.
- Agrees to give consent to participate in the study.
Exclusion Criteria:
- Male
- HIV-positive
- Not willing to self-test onsite under in the presence of the Research Assistant
- Aged <15 years or >19 years
- Does not have a current sexual partner or does not expect to meet the partner at least twice in the next 3 months
- Does not reside in Siaya County or intends to relocate within the next 6 months
- Not interested in obtaining HIV self-tests or HTS referral coupon for purposes of suggesting testing to their sexual partners
- Reporting an incidence of sexual, physical, emotional or economic abuse in the last 12 months from the partner she would have offered self-test kit or referred for testing, or believes the partner may subject her to sexual, physical, emotional, or economic abuse if she offered them self-test kit or HTS coupon.
- Has a male partner who tested within the last 6 months.
- Does not give consent to participate in the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Provision of multiple self-tests
Participants randomized to the intervention group will be given 2-3 HIV oral self-tests to offer to their sexual partner(s).
The participant will be instructed to encourage their partner to test himself alone [partner testing] or with the participant [couple testing]; the partner will also be given a card with information on testing and a list of facilities where he can go for confirmatory testing.
All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information
|
Participants will be given multiple Oraquick Advance HIV-1/2 test kits to distribute to their sexual partners for partner testing or couple testing.
Phone interviews will be conducted with the participants to assess whether they provided a HIV self-test to their partner, if the test was used, how it was used (partner testing or couple testing), if the partner disclosed his results, the partner's reaction to the results, and if the partner went for confirmatory testing
|
Ingen indgriben: Referral vouchers for clinic testing
Participants randomized to the control group will be given multiple referral coupons for HIV testing at pre-selected HIV testing services (HTS) sites.
The participant will be instructed to give the coupon to their sexual partner(s) and encourage him to go for HIV testing at pre-selected HTS sites, either alone [partner testing] or together with the participant [couple testing].
The coupon will also have information on testing and a list of facilities where he can go for HTS.
All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
uptake of partner HIV testing
Tidsramme: 3 months
|
proportion of partners that complete HIV testing
|
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Introduce testing
Tidsramme: 3 months
|
proportion of participants who introduce testing to their partners
|
3 months
|
Partner accept testing
Tidsramme: 3 months
|
proportion of partners who were offered HIVST or referral coupon and accepted
|
3 months
|
Partner testing
Tidsramme: 3 months
|
proportion of participants who report their partner tested alone
|
3 months
|
Couples testing
Tidsramme: 3 months
|
proportion of participants who report testing with their partner
|
3 months
|
Positive partner
Tidsramme: 3 months
|
proportion of participants who report their partner test result was positive
|
3 months
|
linked to care
Tidsramme: 3 months
|
Proportion of participants who report their partners was linked to care
|
3 months
|
Intimate partner violence
Tidsramme: 3 months
|
proportion of participants in each study group who report intimate partner violence related to HIV testing
|
3 months
|
Confirmatory testing for positive HIV self-test
Tidsramme: 3 months
|
proportion of participants in the intervention group who report their partner tested positive and went for confirmatory testing
|
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Kawango Agot, PhD, Impact Organization & Research Development
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- RNA-virusinfektioner
- Virussygdomme
- Infektioner
- Blodbårne infektioner
- Overførbare sygdomme
- Seksuelt overførte sygdomme, virale
- Seksuelt overførte sygdomme
- Lentivirus infektioner
- Retroviridae infektioner
- Immunologiske mangelsyndromer
- Sygdomme i immunsystemet
- Langsomme virussygdomme
- HIV-infektioner
- Erhvervet immundefektsyndrom
Andre undersøgelses-id-numre
- 848410
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Humant immundefektvirus
-
Janssen-Cilag International NVAfsluttetHuman Immundefekt Virus (HIV) Infektioner | Acquired Immunodeficiency Syndrome (AIDS) VirusFrankrig, Det Forenede Kongerige, Belgien, Tyskland, Spanien, Schweiz, Danmark, Israel, Østrig, Polen, Ungarn, Sverige, Irland
-
Public Health EnglandAfsluttetHuman Papillomavirus VirusDet Forenede Kongerige
-
Klein Buendel, Inc.National Cancer Institute (NCI); Indiana University; University of New MexicoAfsluttetHPV | Human Papillomavirus VirusForenede Stater
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLCAfsluttetLivmoderhalskræft | Human Papilloma Virus Infektion Type 11 | Human Papilloma Virus Infektion Type 16 | Human Papilloma Virus Infektion Type 18 | Human Papilloma Virus Infektion Type 6Forenede Stater
-
Columbia UniversityAfsluttetHIV (Human Immunodeficiency Virus)Forenede Stater
-
Columbia UniversityNational Institute of Mental Health (NIMH); Ministry of Health and Social...AfsluttetHIV (Human Immunodeficiency Virus) | AIDS (erhvervet immundefektsyndrom)Tanzania
-
University of California, BerkeleyHealth for a Prosperous Nation; Tanzania Ministry of Health, Community... og andre samarbejdspartnereAktiv, ikke rekrutterendeHIV (Human Immunodeficiency Virus)Tanzania
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID); New York... og andre samarbejdspartnereAfsluttetHIV (Human Immunodeficiency Virus)Swaziland
-
Columbia UniversityNational Institute of Nursing Research (NINR)AfsluttetHIV (Human Immunodeficiency Virus) | AIDS (erhvervet immundefektsyndrom)Forenede Stater
-
Columbia UniversityMinistry of Health, SwazilandAfsluttet
Kliniske forsøg med Provision of multiple self-tests
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbejdspartnereAfsluttet
-
HemoSonics LLCAfsluttet
-
Kirby InstituteRekruttering
-
Foundation for Professional Development (Pty) LtdNational Institute of Allergy and Infectious Diseases (NIAID); University... og andre samarbejdspartnereRekrutteringHIV/AIDS | Graviditet | Omkostningseffektivitet | Svangerskabspleje | Chlamydia Trachomatis | Vaginalt mikrobiom | Fødselsresultater | Seksuelt overført infektion | Neisseria Gonorrhoeae | Trichomonas VaginalisSydafrika
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Ikke rekrutterer endnu
-
Uskudar State HospitalAfsluttet
-
University of CincinnatiMayo Clinic; University of Pennsylvania; Stanford University; Abbott; Jewish...AfsluttetAngina, ustabilForenede Stater
-
Centre for the AIDS Programme of Research in South...Johns Hopkins University; National Institute of Allergy and Infectious...AfsluttetSeksuelt overførte sygdomme | HIV-forebyggelseSydafrika
-
McMaster UniversityTrukket tilbageJernmangel | Overbelastning af jern | Anæmi, jernmangel
-
University of California, San FranciscoUS Department of Veterans Affairs; Agency for Healthcare Research and Quality...Afsluttet